Clinical trials sponsored by National Institute of Allergy and Infectious Diseases (NIAID)

Phase breakdown

Conditions studied

Recruiting trials led by National Institute of Allergy and Infectious Diseases (NIAID)

• A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
  NCT06732414 · Phase: Not specified · Ages: 3 Years to 100 Years · Sex: All (male and female) · 2 locations
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 36 locations
• A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
  NCT07390955 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 11 locations
• A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
  NCT07569029 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 19 locations
• Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
  NCT00001406 · Phase: Not specified · Ages: 1 Year to 100 Years · Sex: All (male and female) · 1 location
• An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
  NCT03167437 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
  NCT00114647 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 23 locations
• Cardamom and Topical Roseomonas in Atopic Dermatitis
  NCT06096857 · Phase: Phase 2 · Ages: 2 Years to 100 Years · Sex: All (male and female) · 1 location
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 9 locations
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
  NCT06796686 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 6 locations
• Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
  NCT07390474 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 7 locations
• Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
  NCT00789009 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
  NCT03937817 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
  NCT00794352 · Phase: Not specified · Ages: 1 Month to 99 Years · Sex: All (male and female) · 1 location
• Dasatinib for HIV-1 Reservoir Reduction
  NCT07342491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study
  NCT05652478 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
  NCT07262983 · Phase: Phase 1 · Ages: 12 Years to 120 Years · Sex: All (male and female) · 1 location
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Expanding HOPE Liver
  NCT07778459 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
  NCT03835767 · Phase: Phase 2 · Ages: 3 Years to 21 Years · Sex: All (male and female) · 1 location
• Immune Regulation in Ulcerative Colitis or Crohn s Disease
  NCT00001184 · Phase: Not specified · Ages: 1 Day to 75 Years · Sex: All (male and female) · 2 locations
• Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy
  NCT06819176 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
  NCT00039689 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
  NCT00029445 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location
• Metabolic Profiling of Immune Responses in Immune-mediated Diseases
  NCT04864886 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Microbiome and Atopy in Mali
  NCT07051902 · Phase: Not specified · Ages: 3 Years and older · Sex: All (male and female) · 4 locations
• Natural History and Genetics of Food Allergy and Related Conditions
  NCT02504853 · Phase: Not specified · Ages: 1 Day to 99 Years · Sex: All (male and female) · 1 location
• Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
  NCT05285891 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 13 locations
• Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
  NCT04052022 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 2 locations
• Protocol CAUSE-03 / CHEETAH
  NCT06136091 · Phase: Not specified · Ages: 6 Years to 17 Years · Sex: All (male and female) · 8 locations
• Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
  NCT02154035 · Phase: Not specified · Ages: 18 Years to 49 Years · Sex: All (male and female) · 1 location
• Registry of Asthma Characterization and Recruitment 3 (RACR3)
  NCT05272241 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 7 locations
• Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers
  NCT03878121 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
  NCT05580458 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Small Trial of Alendronate Impact on the Reservoir of HIV
  NCT07216794 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
  NCT00001281 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · 2 locations
• Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
  NCT07040319 · Phase: Phase 1, Phase 2 · Ages: 16 Years to 45 Years · Sex: Female · 10 locations
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
  NCT06504160 · Phase: Phase 1 · Ages: 6 Years and older · Sex: All (male and female) · 8 locations
• Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
  NCT03109288 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location
• The Tatelo Plus Study
  NCT06508749 · Phase: Phase 1, Phase 2 · Ages: 24 Weeks to 25 Years · Sex: All (male and female) · 2 locations
• VIBRANT: VIB4920 for Active Lupus Nephritis
  NCT05201469 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
  NCT03298334 · Phase: Phase 1, Phase 2 · Ages: 0 Days to 50 Years · Sex: All (male and female) · 1 location
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · 46 locations
• Viral Load in Blood and Lymph Tissues in People Living With HIV
  NCT00001316 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is National Institute of Allergy and Infectious Diseases (NIAID) recruiting for?

National Institute of Allergy and Infectious Diseases (NIAID) is the lead sponsor of 45 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.